ÔçÒÒŮѸÀ×

    • <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      
    

    

      Mirum Pharmaceuticals Inc
      Mirum Pharmaceuticals Inc
      MIRM
      Market Cap$3.71B
       Close$
      
      
      
      
      Compare to Similar Companies
      P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
      Mirum Pharmaceuticals IncMirum Pharmaceuticals Inc-62.7--23%9.51.2
      $85.00
      Target Price by Analysts
      11.8% upsideMirum Pharmaceuticals Target Price DetailsTarget Price
      $27.50
      Current Fair Value
      63.8% downside
      Overvalued by 63.8% based on the discounted cash flow analysis.
      Share Statistics
      Market cap$3.71 Billion
      Enterprise Value$3.80 Billion 
      Dividend Yield$- (-)
      Earnings per Share$-1.85 
      Beta0.95
      Outstanding Shares49,726,823
      Return
      Return on Equity-
      Return on Assets-
      Return on Invested Capital-
      Valuation & Multiples
      P/E Ratio-62.72
      PEG82.3
      Price to Sales9.51
      Price to Book Ratio15.21
      Enterprise Value to Revenue8.86
      Enterprise Value to EBIT-83.75
      Enterprise Value to Net Income-65
      Total Debt to Enterprise0.08
      Debt to Equity1.25
      Revenue Sources
      No data
      Insider Trades
      ESG Score
      No data
      About Mirum Pharmaceuticals Inc
      
      
      


    
      
  
      
    

    
  
      

      

    
      
  To improve your user experience we use
  cookies.
  

      

    
  
  
      
  
      

  
  

  

  
  

  
HoMEÔçÒÒŮѸÀ×